Impact of the Hepatopulmonary Syndrome MELD Exception Policy on Outcomes of Patients After Liver Transplantation: An Analysis of the UNOS Database

被引:77
作者
Goldberg, David S. [1 ,2 ]
Krok, Karen [3 ]
Batra, Sachin [4 ]
Trotter, James F. [5 ]
Kawut, Steven M. [2 ,6 ]
Fallon, Michael B. [4 ]
机构
[1] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
[2] Univ Penn, Clin Ctr Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Hershey Med Ctr, Div Gastroenterol, Dept Med, Hershey, PA USA
[4] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA
[5] Baylor Univ, Dept Hepatol, Simmons Transplant Inst, Dallas, TX USA
[6] Univ Penn, Pulm Allergy & Crit Care Div, Perelman Sch Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
UNOS; MELD; Allocation; Gas Exchange; SURVIVAL-DATA ANALYSIS; COMPETING RISKS; DISEASE MELD; PORTOPULMONARY HYPERTENSION; HEPATOCELLULAR-CARCINOMA; PULSE OXIMETRY; MODEL; CANDIDATES; ALLOCATION; MORTALITY;
D O I
10.1053/j.gastro.2014.01.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Patients with hepatopulmonary syndrome (HPS) are prioritized for liver transplantation (given exception points) due to their high pre- and post-transplantation mortality. However, few studies have evaluated the outcomes of these patients. METHODS: We performed a retrospective cohort study using data submitted to the United Network for Organ Sharing in a study of the effects of room-air oxygenation on pre- and post-transplantation outcomes of patients with HPS. We identified thresholds associated with post-transplantation survival using cubic spline analysis and compared overall survival times of patients with and without HPS. RESULTS: From 2002 through 2012, nine hundred and seventy-three patients on the liver transplant waitlist received HPS exception points. There was no association between oxygenation and waitlist mortality among patients with HPS exception points. Transplant recipients with more severe hypoxemia had increased risk of death after liver transplantation. Rates of 3-year unadjusted post-transplantation survival were 84% for patients with PaO2 of 44.1 - 54.0 mm Hg vs 68% for those with PaO2 <= 44.0 mm Hg. In multivariable Cox models, transplant recipients with an initial room-air PaO2 <= 44.0 mm Hg had significant increases in post-transplantation mortality (hazard ratio = 1.58; 95% confidence interval [CI]: 1.15 - 2.18) compared with those with a PaO2 of 44.1 - 54.0 mm Hg. Overall mortality was significantly lower among waitlist candidates with HPS exception points than those without (hazard ratio = 0.82; 95% CI: 0.70 - 0.96), possibly because patients with HPS have a reduced risk of pre-transplantation mortality and similar rate of post-transplantation survival. CONCLUSIONS: Although there was no association between pre-transplantation oxygenation and waitlist survival in patients with HPS Model for End-Stage Liver Disease exception points, a pre-transplantation room-air PaO2 <= 44.0 mm Hg was associated with increased post-transplantation mortality. HPS Model for End-Stage Liver Disease exception patients had lower overall mortality compared with others awaiting liver transplantation, suggesting that the appropriateness of the HPS exception policy should be reassessed.
引用
收藏
页码:1256 / +
页数:11
相关论文
共 42 条
  • [11] A proportional hazards model for the subdistribution of a competing risk
    Fine, JP
    Gray, RJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) : 496 - 509
  • [12] Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula
    Freeman, Richard B., Jr.
    Gish, Robert G.
    Harper, Ann
    Davis, Gary L.
    Vierling, John
    Lieblein, Leslie
    Klintmalm, Goran
    Blazek, Jamie
    Hunter, Robert
    Punch, Jeffrey
    [J]. LIVER TRANSPLANTATION, 2006, 12 (12) : S128 - S136
  • [13] Analysis of longitudinal data to evaluate a policy change
    French, Benjamin
    Heagerty, Patrick J.
    [J]. STATISTICS IN MEDICINE, 2008, 27 (24) : 5005 - 5025
  • [14] Pulmonary Vascular Complications of Liver Disease
    Fritz, Jason S.
    Fallon, Michael B.
    Kawut, Steven M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (02) : 133 - 143
  • [15] Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma
    Goldberg, David
    French, Benjamin
    Abt, Peter
    Feng, Sandy
    Cameron, Andrew M.
    [J]. LIVER TRANSPLANTATION, 2012, 18 (04) : 434 - 443
  • [16] Improved Survival After Liver Transplantation in Patients with Hepatopulmonary Syndrome
    Gupta, S.
    Castel, H.
    Rao, R. V.
    Picard, M.
    Lilly, L.
    Faughnan, M. E.
    Pomier-Layrargues, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (02) : 354 - 363
  • [17] REGRESSION-MODELS IN CLINICAL-STUDIES - DETERMINING RELATIONSHIPS BETWEEN PREDICTORS AND RESPONSE
    HARRELL, FE
    LEE, KL
    POLLOCK, BG
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (15) : 1198 - 1202
  • [18] Portopulmonary hypertension and hepatopulmonary syndrome
    Hoeper, MM
    Krowka, MJ
    Strassburg, CP
    [J]. LANCET, 2004, 363 (9419) : 1461 - 1468
  • [19] Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era
    Iyer, Vivek N.
    Swanson, Karen L.
    Cartin-Ceba, Rodrigo
    Dierkhising, Ross A.
    Rosen, Charles B.
    Heimbach, Julie K.
    Wiesner, Russell H.
    Krowka, Michael J.
    [J]. HEPATOLOGY, 2013, 57 (06) : 2427 - 2435
  • [20] A model to predict survival in patients with end-stage liver disease
    Kamath, PS
    Wiesner, RH
    Malinchoc, M
    Kremers, W
    Therneau, TM
    Kosberg, CL
    D'Amico, G
    Dickson, ER
    Kim, WR
    [J]. HEPATOLOGY, 2001, 33 (02) : 464 - 470